Cargando…

The status of TKI/acid-suppressant concomitant use in 44 hospitals in China: A cross-sectional descriptive study

The irrational use of tyrosine kinase inhibitors (TKIs) has attracted increasing attention, especially because of drug–drug interactions. The objective of this study was to analyze TKI prescriptions and evaluate the rationality of concomitant use of TKIs and acid-suppressants. TKI prescriptions from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fangting, Yao, Wendong, Wu, Fan, Xie, Rui, Wang, Jianping, Shi, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678504/ https://www.ncbi.nlm.nih.gov/pubmed/36401366 http://dx.doi.org/10.1097/MD.0000000000031770

Ejemplares similares

Impact of heavy smoking on the benefits from first-line EGFR-TKI therapy in patients with advanced lung adenocarcinoma
por: Zhang, Ping, et al.
Publicado: (2018)

Long-term survival of advanced lung adenocarcinoma by maintenance chemotherapy followed by EGFR-TKI: A case report
por: Chen, Hui Jun, et al.
Publicado: (2021)

The predictive and prognostic effects of PD-L1 expression on TKI treatment and survival of EGFR-mutant NSCLC: A meta-analysis
por: Lan, Bo, et al.
Publicado: (2021)

Anlotinib, a novel TKI, as a third-line or further-line treatment in patients with advanced non-small cell lung cancer in China: A systemic review and meta-analysis of its efficacy and safety
por: Ye, Haiyong, et al.
Publicado: (2021)

Efficacy and safety of Kanglaite plus EGFR-TKI in the treatment of advanced non-small cell lung cancer: A meta-analysis of 13 RCTs
por: Li, Dailong, et al.
Publicado: (2022)

Efficacy of 3rd generation TKI in patients with EGFR mutation lung adenocarcinoma with bone metastases: A review of 3 case reports and literature
por: Guo, Qiang, et al.
Publicado: (2023)

Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports
por: Lai, Lin, et al.
Publicado: (2021)

Long-term survival in a patient with advanced non-smoking lung adenocarcinoma and no EGFR mutation after comprehensive therapy with EGFR-TKI-based therapy: A case report
por: Zhang, Qianyu, et al.
Publicado: (2022)

The current status of treatment for colorectal cancer in China: A systematic review
por: Zhang, Yumei, et al.
Publicado: (2017)

KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China
por: Lian, Shen-Yi, et al.
Publicado: (2023)

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with bevacizumab for advanced non-squamous non-small-cell lung cancer patients with gradual progression on EGFR-TKI treatment: A cohort study
por: Yu, Yuman, et al.
Publicado: (2021)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Diagnostic Value of Wilms Tumor 1 and CD44 in Langerhans Cell Sarcoma: Case Series of 4 Patients
por: Wang, Chang-song, et al.
Publicado: (2015)

Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis
por: Zeng, Li, et al.
Publicado: (2020)

Effects of flavopiridol on critical regulation pathways of CD133(high)/CD44(high) lung cancer stem cells
por: Bozok Cetintas, Vildan, et al.
Publicado: (2016)

CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis
por: Lu, Li, et al.
Publicado: (2016)

Pineal Diffuse Large B-Cell Lymphoma Concomitant With Pituitary Prolactinoma: Possible Correlation Between 2 Distinguished Pathologies: A Case Report
por: Kim, Yeong-Jin, et al.
Publicado: (2016)

The model of descriptive, diagnostic, predictive, and prescriptive analytics on 100 top-cited articles of nasopharyngeal carcinoma from 2013 to 2022: Bibliometric analysis
por: Hung, Chung-Chia, et al.
Publicado: (2023)

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Sen, Fatma, et al.
Publicado: (2016)

Sera total oxidant/antioxidant status in lung cancer patients
por: Xiang, Miao, et al.
Publicado: (2019)

Traditional Chinese medicine suppressed cancer progression by targeting endoplasmic reticulum stress responses: A review
por: Xia, Fan, et al.
Publicado: (2022)

Changes in Socioeconomic Inequality of Low Birth Weight and Macrosomia in Shaanxi Province of Northwest China, 2010–2013: A Cross-sectional Study
por: Pei, Leilei, et al.
Publicado: (2016)

Association between Chinese herbal medicine (CHM) treatment and depression among cancer patients in China: An outpatient-based cross-sectional study
por: Lin, Huiyue, et al.
Publicado: (2023)

Breast cancer combined prognostic model based on lactate metabolism genes
por: Lu, Na, et al.
Publicado: (2022)

Colorectal patients’ readiness for hospital discharge following management of enhanced recovery after surgery pathway: A cross-sectional study from China
por: Yang, Jie, et al.
Publicado: (2020)

Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China: A retrospective analysis
por: Xie, Yuxin, et al.
Publicado: (2017)

Retrospective analysis of the bleeding risk induced by oral antiplatelet drugs during radiotherapy
por: Xi, Dan, et al.
Publicado: (2021)

A case report of local treatment of inoperable squamous cell lung carcinoma with convex-probe endobronchial ultrasound-guided intratumoral injection of cisplatin in a patient with severe COPD
por: Li, Xiaochen, et al.
Publicado: (2017)

Assessment of Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Breast Carcinoma Using Thin-Prep Cytology Fine Needle Aspiration Cytology FISH Experience From China
por: Zhang, Zhihui, et al.
Publicado: (2015)

Alectinib in the treatment of ocular metastases of ALK rearranged non small cell lung cancer: Description of 2 case reports
por: Gozzi, Elisa, et al.
Publicado: (2020)

Retrospective analysis of cervical cancer and precancerous lesions in patients with atypical squamous cells of undetermined significance in China
por: Wang, Yan-Ying, et al.
Publicado: (2019)

The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking
por: Xie, Rui-fei, et al.
Publicado: (2022)

(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
por: Guan, Jian, et al.
Publicado: (2016)

Cadmium Status Among Pediatric Cancer Patients in Egypt
por: Sherief, Laila M., et al.
Publicado: (2015)

Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers
por: Chen, Yanglong, et al.
Publicado: (2019)

Using temporal heatmaps to identify worthwhile articles on immune checkpoint blockade for melanoma (ICBM) in Mainland China, Hong Kong, and Taiwan since 2000: A bibliometric analysis
por: Juang, Shiow-Jen, et al.
Publicado: (2023)

Effect of platinum-based chemotherapy on EGFR gene mutation status in lung adenocarcinoma
por: Wang, Yuli, et al.
Publicado: (2018)

Plasma metabolite profiling reveals potential biomarkers of giant cell tumor of bone by using NMR-based metabolic profiles: A cross-sectional study
por: Wang, Wei, et al.
Publicado: (2019)

Menopausal status and the risk of lung cancer in women: A PRISMA-compliant meta-analysis
por: Min, Lingfeng, et al.
Publicado: (2017)

Marital status is an independent prognostic factor for cervical adenocarcinoma: A population-based study
por: Zhou, Di, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t891ijosn2hffd7m0n0jdse1pa